Rigel sells IPO, plus shares to Novartis

RIGL raised $35 million through the sale of 5 million shares at $7 in its

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE